Vivos (RDGL) Other Non Operating Income (2011 - 2022)
Vivos (RDGL) reported Other Non Operating Income of $47588.0 for Q1 2022, up 126.99% on a YoY basis from $20964.5 in Q1 2021, and up 113.42% sequentially from -$354505.0 in Q4 2021.
Vivos (RDGL) Other Non Operating Income (2011 - 2022) Analysis & Trends
Vivos (RDGL) has 12 years of Other Non Operating Income data on file, last reported at $47588.0 in Q1 2022.
- For the quarter ending Q1 2022, Other Non Operating Income rose 126.99% year-over-year to $47588.0; the trailing twelve-month figure through Dec 2022 stood at $47588.0 (up 108.97% YoY), and the FY2025 full-year result was $216100.0, up 12.03% from the prior year.
- Other Non Operating Income grew to $47588.0 in Q1 2022, from -$354505.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $28.6 million in Q4 2018 to a low of -$27.1 million in Q3 2018.
- A 5-year average of $110875.7 and a median of $2950.0 in 2020 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 4077.68% in 2018, while the deepest fall reached 301215366.67% in 2018.
- Tracing RDGL's Other Non Operating Income over 5 years: stood at $28.6 million in 2018, then sank by 100.18% to -$52850.0 in 2019, then jumped by 105.49% to $2900.0 in 2020, then sank by 12324.31% to -$354505.0 in 2021, then surged by 113.42% to $47588.0 in 2022.
- Business Quant data shows RDGL's Other Non Operating Income at $47588.0 in Q1 2022, -$354505.0 in Q4 2021, and -$176295.0 in Q1 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 47,588.00 |
| Dec 31, 2021 | -354,505.00 |
| Mar 31, 2021 | -176,295.00 |
| Dec 31, 2020 | 2,900.00 |
| Jun 30, 2020 | 3,000.00 |
| Dec 31, 2019 | -52,850.00 |
| Sep 30, 2019 | 34,106.00 |
| Dec 31, 2018 | 28.58 Mn |
| Sep 30, 2018 | -27.11 Mn |
| Jun 30, 2018 | 131,604.00 |
| Dec 31, 2017 | -718,574.00 |
| Sep 30, 2017 | 9.00 |
| Jun 30, 2017 | -201,574.00 |
| Mar 31, 2017 | 147,710.00 |
| Dec 31, 2016 | 6.22 Mn |
| Sep 30, 2016 | 762,151.00 |
| Jun 30, 2016 | 1.27 Mn |
| Mar 31, 2016 | -5.14 Mn |
| Dec 31, 2015 | -5.19 Mn |
| Sep 30, 2015 | 144,290.00 |